About Dimension Therapeutics
Dimension Therapeutics is a company based in Cambridge (United States) founded in 2013 was acquired by Ultragenyx in October 2017.. Dimension Therapeutics has raised $119.5 million across 4 funding rounds from investors including Ultragenyx, New Leaf Venture Partners and Orbimed. The company has 53 employees as of December 31, 2017. Dimension Therapeutics operates in a competitive market with competitors including Moderna, BridgeBio, Spark Therapeutics, Alnylam and ATAI, among others.
- Headquarter Cambridge, United States
- Employees 53 as on 31 Dec, 2017
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Dimension Therapeutics, Inc.
-
Annual Revenue
$11.47 M48as on Dec 31, 2016
-
Net Profit
$-49 M-40as on Dec 31, 2016
-
EBITDA
$-49.05 M-40as on Dec 31, 2016
-
Total Equity Funding
$119.5 M (USD)
in 4 rounds
-
Latest Funding Round
$65 M (USD), Series B
Apr 23, 2015
-
Investors
Ultragenyx
& 7 more
-
Employee Count
53
as on Dec 31, 2017
-
Acquired by
Ultragenyx
(Oct 03, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Dimension Therapeutics
Dimension Therapeutics has successfully raised a total of $119.5M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $65 million completed in April 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $65.0M
- First Round First Round
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2015 | Amount | Series B - Dimension Therapeutics | Valuation | Jennison , RA Capital Management |
|
| Feb, 2015 | Amount | Series B - Dimension Therapeutics | Valuation |
investors |
|
| Nov, 2014 | Amount | Series A - Dimension Therapeutics | Valuation | Orbimed , F-Prime Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Dimension Therapeutics
Dimension Therapeutics has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Ultragenyx, New Leaf Venture Partners and Orbimed. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage and late-stage biotech and finance companies are funded.
|
Founded Year | Domain | Location | |
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
Investments in life sciences, technology, healthtech, and crypto sectors from global locations.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Dimension Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Dimension Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Dimension Therapeutics Comparisons
Competitors of Dimension Therapeutics
Dimension Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BridgeBio, Spark Therapeutics, Alnylam and ATAI, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Dimension Therapeutics
Frequently Asked Questions about Dimension Therapeutics
When was Dimension Therapeutics founded?
Dimension Therapeutics was founded in 2013.
Where is Dimension Therapeutics located?
Dimension Therapeutics is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is Dimension Therapeutics a funded company?
Dimension Therapeutics is a funded company, having raised a total of $119.5M across 4 funding rounds to date. The company's 1st funding round was a Series A of $30M, raised on Jun 01, 2013.
How many employees does Dimension Therapeutics have?
As of Dec 31, 2017, the latest employee count at Dimension Therapeutics is 53.
What is the annual revenue of Dimension Therapeutics?
Annual revenue of Dimension Therapeutics is $11.47M as on Dec 31, 2016.
What does Dimension Therapeutics do?
Dimension Therapeutics was founded in 2013 in Cambridge, United States. Operations center on biotechnology within the gene therapy sector, where a platform for adeno-associated virus (AAV) therapeutics is utilized to address rare genetic diseases. Clinical development is pursued, beginning with lead programs for hemophilia. The approach involves creating targeted treatments for conditions with limited options, supported by ongoing research and trials in the United States.
Who are the top competitors of Dimension Therapeutics?
Dimension Therapeutics's top competitors include Moderna, Spark Therapeutics and BridgeBio.
Who are Dimension Therapeutics's investors?
Dimension Therapeutics has 8 investors. Key investors include Ultragenyx, New Leaf Venture Partners, Orbimed, RA Capital, and Jennison Associates.